Three years ago, Public Citizen issued a report that documents all of the settlements between pharmaceutical giants and the federal and state governments due to violations such as overcharging patients or by off-label marketing. At the time the tally was about $20 billion covering a period of 20 years. The […]
Search Results: avandia
One has to wonder how this will play with stockholders. Johnson & Johnson, the healthcare giant, has agreed to pay more than $2.2 billion to settle criminal charges over the marketing of its antipsychotic drug, Risperdal. The company’s Janssen Pharmaceuticals division is accused of marketing the drug to treat elderly […]
The search has been on for a new and improved drug treatment for type 2 diabetes that would leave the complications of Avandia in the past. That hasn’t happened. New Class of Diabetes Drugs, DPP-4 The latest findings concern a newer class of diabetes drugs called DPP-4 that lower blood […]
Where, oh where does clinical trial data go? Earlier this year, the British Medical Journal (BMJ) wrote that a large proportion of evidence from human clinical trials goes missing while cherry-picked favorable data appears. According to the BMJ, fewer than half of the data from clinical trials run using National […]
It used to be that the arms industry was the bad boy of all industries. Move over! Big Pharma has now topped the gun trade with a $3 billion fine imposed on GlaxoSmithKline (GSK). Britain’s largest pharmaceutical company, GSK, was just busted for offering lavish incentives to doctors to promote […]
(It Doesn’t Really Matter As Long As Patients and Surgeons Stop Buying the Defective Implants!) While it would certainly be nice to have a government that moved swiftly to recall defective drugs and medical devices from the market, we do not live in that world – at least in the […]
The Top Ten of anything usually designates the ‘best’ but not in this case. An online report from Adverse Events Inc., an independent company that analyzes the FDA’s database of Adverse Event Reporting System (AERS), has just issued its Top Ten list of Dangerous Drugs for the second quarter Q2 […]
A recently unsealed complaint filed by whistleblower Helen Ge reveals that over four years, Takeda Pharmaceuticals failed to report to the FDA congestive heart failure cases in patients taking Actos. Takeda manufactures the Type II diabetes drug Actos. Actos is the third in a long line of failed Type II […]
The United States Justice Department has fined British drug company GlaxoSmithKline $3 billion for failing to accurately report safety data related to two of its most popular drugs, Wellbutrin and Paxil. The fine is divided – $2 billion to resolve the largest fraud settlement in U.S. history and $1 billion […]
When faced with a possible danger, how much of a warning do you need? As far as the Food and Drug Administration is concerned, your tolerance for risk is pretty high. And what about its responsibility for sounding the alarm? Eh, that can wait a while. When picking up a […]